Galera Therapeutics, Inc.

Galera Therapeutics, Inc. is a firm with limited publicly available information. No AUM, principals, or investment strategy are disclosed.

Galera Therapeutics, Inc.

Transforming the science and treatment of cancer | Galera Therapeutics is focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.

linkedin.com/company/galera-therapeutics-inc

General information

Firm type

Single Family Office

Year founded

—

AUM

Undisclosed

Location

Region

—

Country

—

City

—

Corporate office

—

Who runs investment decisions at Galera Therapeutics, Inc.?

No named individuals or leadership team have been publicly documented for Galera Therapeutics, Inc. The firm does not list its investment committee or decision-makers on public records.

What is Galera Therapeutics, Inc.'s investment strategy?

The investment strategy of Galera Therapeutics, Inc. is not publicly disclosed. No information is available regarding its asset-class mix, target stages, or sector preferences.

Does Galera Therapeutics, Inc. have any known portfolio companies?

No portfolio companies, deals, or co-investments have been publicly attributed to Galera Therapeutics, Inc. Its investment holdings remain undisclosed.

Where is Galera Therapeutics, Inc. based?

The headquarters location for Galera Therapeutics, Inc. has not been publicly identified. No office addresses are available through open sources.

How is Galera Therapeutics, Inc. structured?

The firm is registered as a corporation, but its operational structure—whether it functions as a family office, holding company, or investment vehicle—is not publicly specified.

Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: Jun 3, 2026. Continuous refresh with full update cycles at least every 30 days.